Australia markets closed

Orphazyme A/S (OZYMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0900+0.0900 (+8,999,900.00%)
As of 04:22PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
36,193
36,193
0
Operating expenses
Research development
229,942
229,942
261,136
Selling general and administrative
391,395
421,443
342,199
Total operating expenses
639,448
669,496
608,534
Operating income or loss
-603,255
-633,303
-608,534
Interest expense
9,458
9,458
14,114
Total other income/expenses net
-
11,391
-12,406
Income before tax
-601,400
-631,480
-635,161
Income tax expense
-5,416
-4,941
-1,915
Income from continuing operations
-595,984
-626,539
-633,246
Net income
-99,776
-626,539
-633,246
Net income available to common shareholders
-99,776
-626,539
-633,246
Basic EPS
-2.88k
-17.94k
-22.32k
Diluted EPS
-2.88k
-17.94k
-22.32k
Basic average shares
35.098
34.924
28.366
Diluted average shares
35.312
34.924
28.366